Cargando…

Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?

INTRODUCTION: Pustular palmoplantar psoriasis (PPP) is a rare type of psoriasis affecting mainly distal parts of the limbs. Despite numerous theories about etiology of PPP, the pathogenesis still remains unclear. Recent data indicate that interleukin (IL)-15, IL-17 and IL-22 enhance a proinflammator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lesiak, Aleksandra, Bednarski, Igor, Pałczyńska, Marta, Kumiszcza, Ewelina, Kraska-Gacka, Marzena, Woźniacka, Anna, Narbutt, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110622/ https://www.ncbi.nlm.nih.gov/pubmed/27881938 http://dx.doi.org/10.5114/ada.2016.62838

Ejemplares similares

Interleukin 22 and 6 serum concentrations decrease under long-term biologic therapy in psoriasis
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2020)

Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers
por: Kolano, Paweł, et al.
Publicado: (2021)

AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021)

Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Prospective 3-month study on the efficacy of UV-free blue light in mild psoriasis vulgaris treatment
por: Lesiak, Aleksandra, et al.
Publicado: (2021)

Tozinameran: Exacerbations of generalised pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris: 3 case reports
Publicado: (2022)

Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: a Report of Two Cases
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Teriflunomide-Induced Palmoplantar Pustular Psoriasis: Case Report and Review of the Literature
por: Demirel Ozbek, Ezgi, et al.
Publicado: (2023)

Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
por: Ständer, Sascha, et al.
Publicado: (2020)

Simultaneous occurrence of Pyoderma Gangrenosum and Palmoplantar Pustular Psoriasis: Is it an association or coincidental findings?
por: Pukar, Chapagain, et al.
Publicado: (2020)

Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

Commentary: Successful treatment of refractory palmoplantar pustular psoriasis with apremilast: a case series
por: Hackley, Madison, et al.
Publicado: (2023)

Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis – a real life retrospective study
por: Galica, Katarzyna, et al.
Publicado: (2020)

Interleukin-18, interleukin-20, and matrix metalloproteinases (MMP-1, MMP-3) as markers of psoriatic arthritis disease severity and their correlations with biomarkers of inflammation and turnover of joint cartilage
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients()()
por: Xiaoling, Yu, et al.
Publicado: (2019)

Omalizumab for urticaria treatment in clinical practice: a case series
por: Lesiak, Aleksandra, et al.
Publicado: (2018)

Pustular Palmoplantar Psoriasis Successfully Treated with Nb-UVB Monochromatic Excimer Light: A Case-Report
por: Gianfaldoni, Serena, et al.
Publicado: (2017)

Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
por: Lesiak, Aleksandra, et al.
Publicado: (2019)

The effect of an emollient with benfothiamine and Biolin prebiotic on the improvement of epidermal skin function
por: Narbutt, Joanna, et al.
Publicado: (2016)

One week of exposure to sunlight induces progerin expression in human skin
por: Lesiak, Aleksandra, et al.
Publicado: (2017)

Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond
por: Sugiura, Kazumitsu
Publicado: (2022)

Improvement of Anti-TNF-α Antibody-Induced Palmoplantar Pustular Psoriasis Using a 308-nm Excimer Light
por: Iga, Natsuko, et al.
Publicado: (2012)

Trends in basal cell carcinoma incidence rates: a 16-year retrospective study of a population in central Poland
por: Ciążyńska, Magdalena, et al.
Publicado: (2018)

Palmoplantar syphilis misdiagnosed and treated as palmoplantar psoriasis for 2 years
por: Solak, Berna, et al.
Publicado: (2016)

Beating Palmoplantar Psoriasis Away
por: D’Souza, Paschal V
Publicado: (2012)

Successful treatment of a child’s generalized pustular psoriasis with adalimumab in combination with low-dose acitretin
por: Arasiewicz, Hubert, et al.
Publicado: (2023)

NLRP1 and NLRP3 inflammasomes as a new approach to skin carcinogenesis
por: Ciążyńska, Magdalena, et al.
Publicado: (2020)

Analysis of dermoscopic characteristic for the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema
por: Yu, Xiaoping, et al.
Publicado: (2021)

Telmisartan aggravates pustular psoriasis
por: Keerthi, Subramaniam, et al.
Publicado: (2015)

Secukinumab in Generalized Pustular Psoriasis
por: Madanagobalane, Shraddha
Publicado: (2018)

Pathophysiology of Generalized Pustular Psoriasis
por: Marrakchi, Slaheddine, et al.
Publicado: (2022)

Diagnosis of Generalized Pustular Psoriasis
por: Fujita, Hideki, et al.
Publicado: (2022)

Serum and synovial fluid concentrations of interleukin-18 and interleukin-20 in patients with osteoarthritis of the knee and their correlation with other markers of inflammation and turnover of joint cartilage
por: Waszczykowski, Michał, et al.
Publicado: (2020)

The influence of tumour necrosis factor α inhibitors treatment – etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability
por: Narbutt, Joanna, et al.
Publicado: (2023)

Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis
por: Spencer, Riley K., et al.
Publicado: (2023)

Secondary Syphilis Presenting As Palmoplantar Psoriasis
por: Gianfaldoni, Serena, et al.
Publicado: (2017)

Palmoplantar Psoriasis Successfully Treated With Risankizumab
por: Alajlan, Abdulmajeed M, et al.
Publicado: (2021)

Serum Biomarkers of Inflammation and Turnover of Joint Cartilage Can Help Differentiate Psoriatic Arthritis (PsA) Patients from Osteoarthritis (OA) Patients
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mj3ojtr1kd0a9raan92v9hkcd8